While anti-angiogenic functions of PEDF have been best characterized, down regulation of PEDF in a poorly vascularized tumor such as pancreatic cancer [43–45] suggests other potential anti-tumoral mechanisms for PEDF in this context. The gene discussed is SERPINF1; the disease is pancreatic neoplasm.